ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.80
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,713.17
      0.48%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX
      6. AgeX Therapeutics Inc (AGE)

      7. AgeX Therapeutics Inc (AGE) News

      AGE

      AgeX Therapeutics (AGE)

      AgeX Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:AMEX:AGE
      DateTimeSourceHeadlineSymbolCompany
      03/22/20245:27PMGlobeNewswire Inc.AgeX Therapeutics Reports Fourth Quarter and Annual 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
      03/07/20244:49PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsAMEX:AGEAgeX Therapeutics Inc
      03/07/20244:47PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      03/07/20247:47AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
      02/14/20244:01PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
      02/14/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AGEAgeX Therapeutics Inc
      02/06/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      02/05/20247:19AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
      01/19/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      01/18/20245:29PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:AGEAgeX Therapeutics Inc
      01/17/20244:19PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
      01/16/20249:11AMEdgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]AMEX:AGEAgeX Therapeutics Inc
      01/11/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      01/09/20244:16PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
      01/05/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      12/28/20234:02PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      12/18/20234:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      12/13/20235:11PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
      12/08/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      12/01/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      11/17/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      11/16/20234:01PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
      11/15/20239:38AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
      11/14/20234:25PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      11/14/20234:05PMBusiness WireAgeX Therapeutics Reports Third Quarter 2023 Financial ResultsAMEX:AGEAgeX Therapeutics Inc
      11/07/20234:06PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AGEAgeX Therapeutics Inc
      11/07/20234:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AGEAgeX Therapeutics Inc
      11/06/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
      11/01/20234:28PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:AGEAgeX Therapeutics Inc
      10/06/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AGEAgeX Therapeutics Inc
       Showing the most relevant articles for your search:AMEX:AGE